Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

TSX:ATE - Post by User

Antibe Therapeutics Inc(Pre-Merger)

<< Previous

Bullboard Posts

Next >>

Post by Duster340on Jan 15, 2024 10:59am

186 Views

Post# 35826915

Insider Buying

no one selling their vested rsu's but instead trading for common shares. although not a huge amount

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Jan 13/24	Jan 11/24	McNealey, Jennifer	Direct Ownership	Common Shares	57 - Exercise of rights	11,666	$1.07
Jan 13/24	Jan 11/24	McNealey, Jennifer	Direct Ownership	Restricted Share Units	57 - Exercise of rights	-11,666	$1.07
Jan 13/24	Jan 11/24	Hoffman, Robert	Direct Ownership	Common Shares	57 - Exercise of rights	11,666	$1.07
Jan 13/24	Jan 11/24	Hoffman, Robert	Direct Ownership	Restricted Share Units	57 - Exercise of rights	-11,666	$1.07
Jan 13/24	Jan 11/24	Wu, Yung Cheng	Direct Ownership	Common Shares	57 - Exercise of rights	13,334	$1.07
Jan 13/24	Jan 11/24	Wu, Yung Cheng	Direct Ownership	Restricted Share Units	57 - Exercise of rights	-13,334	$1.07
Jan 13/24	Jan 11/24	Khouri, Amal	Direct Ownership	Common Shares	57 - Exercise of rights	40,000	$1.07
Jan 13/24	Jan 11/24	Khouri, Amal	Direct Ownership	Restricted Share Units	57 - Exercise of rights	-40,000	$1.07
Jan 13/24	Jan 11/24	Flower, Roderick John	Direct Ownership	Common Shares	57 - Exercise of rights	13,334	$1.07
Jan 13/24	Jan 11/24	Flower, Roderick John	Direct Ownership	Restricted Share Units	57 - Exercise of rights	-13,334	$1.07